themarkfdn.bsky.social - Profile | ThreadSky | a Reddit-style client for Bluesky

We're proud to partner with @cancerresearchuk.org to support world-leading #cancerresearch, including through the @cancergrand.bsky.social teams we co-sponsor. These kinds of collaborations are essential to driving progress in the fight against cancer. www.thirdsector.co.uk/largest-phil...

submitted 3 days ago • 0 comments

Fantastic visit to @crick.ac.uk yesterday! It’s always a pleasure to get an update on their world-class research. Thanks for the warm welcome. #CancerResearch

submitted 4 days ago • 0 comments

It’s #GallbladderCancerAwarenessMonth & #BileDuctCancerAwarenessMonth — and together with @theaacr.bsky.social & @lustgarten.org, we’re funding an Early Detection Award targeting these and other recalcitrant cancers. Letters of intent are due March 10! themarkfoundation.org/early-detect...

submitted 6 days ago • 0 comments

Supported by @theaacr.bsky.social & @themarkfdn.bsky.social we're awarding Travel Grants to help EACR & AACR members who need financial assistance to attend the 36th Pezcoller Symposium! Deadline: 31 March eacr.org/travel-grant...

submitted 10 days ago • 0 comments

Neoantigen vaccines offer a promising new approach to personalized cancer immunotherapy — but challenges remain. In two new @nature.com papers, Mark Foundation grantees offer critical insights on the path forward.

submitted 11 days ago • 1 comment

New breakthrough in the fight against #chordoma! In @naturecomms.bsky.social, researchers funded by The Mark Foundation & Chordoma Foundation map the structure of brachyury, a transcription factor that drives tumor growth, and point to potential drug-binding sites. www.nature.com/articles/s41...

submitted 12 days ago • 1 comment

Physician-scientists play a critical role in cancer research, & we’re thrilled that 5 Mark Foundation grantees were elected to @the-asci.bsky.social this year. Congratulations to Jorge Henao-Mejia, Tobias Janowitz, Robert Jenq, Robbie Majzner, & Daniel Wahl! themarkfoundation.org/blog/five-ma...

submitted 18 days ago • 0 comments

⌛️Reminder!⌛️ We are currently accepting proposals for an ASPIRE Award focused on intrinsically disordered proteins and cancer. Letters of intent are due Feb 28—submit yours soon! themarkfoundation.org/aspire-idp/ #CancerResearch #ResearchFunding

submitted 19 days ago • 0 comments

#BiliaryTractCancers are difficult to diagnose early, limiting treatment options. With @theaacr.bsky.social & @lustgarten.org, we are seeking proposals for projects focused on early detection of these & other recalcitrant cancers. themarkfoundation.org/early-detect... #BiliaryTractCancerAwarenessDay

submitted 21 days ago • 0 comments

Checkpoint inhibitors can be powerful immunotherapies—but identifying the immune cells they target has been elusive. MANAscore, developed by researchers at the Mark Foundation Center for Advanced Genomics & Imaging at Johns Hopkins, helps find these cells. www.hopkinsmedicine.org/news/newsroo...

submitted 24 days ago • 0 comments

Which trends in cancer research will shape progress in 2025 and beyond? Mark Foundation CEO Ryan Schoenfeld shares his thoughts in a Labiotech.eu roundup: www.labiotech.eu/in-depth/onc... #Immunotherapy #CancerResearch

submitted 25 days ago • 0 comments

The future of cancer care hinges on the discoveries we make today. This #WorldCancerDay, The Mark Foundation reaffirms our commitment to funding groundbreaking research and fostering global collaborations among scientists.

submitted 27 days ago • 0 comments

How can we ensure cancer research thrives despite current uncertainties? Mark Foundation CEO Ryan Schoenfeld and Board Chair Ray DuBois share their perspective: cancerletter.com/guest-editor... @cancerletter.com

submitted 28 days ago • 0 comments

Happening tomorrow! Join our Meet the Expert webinar with Stamatis Papathanasiou, the EACR-The Mark Foundation-Pezcoller Rising Star Award winner 2024. He will be discussing his research on mitotic errors as a novel source of inherited (epi)genetic instability. us02web.zoom.us/webinar/regi...

submitted 33 days ago • 1 comment

Congratulations to @martakova.bsky.social, winner of the 2025 @helloeacr.bsky.social-Mark Foundation-Pezcoller Foundation Rising Star Award!🌟 Kovatcheva, the award’s third recipient, will use her funding to support work on epithelial cell plasticity. Learn more: themarkfoundation.org/2025/01/54273/

submitted 39 days ago • 0 comments

📢 Funding opportunity! 📢 Following last week’s workshop, we are accepting proposals for an ASPIRE Award focused on intrinsically disordered proteins and cancer. Letters of intent are due Feb 28. #CancerResearch #ResearchFunding themarkfoundation.org/aspire-idp/

submitted 41 days ago • 0 comments

Quite simply, one of the best things I've done, been involved with, and participated in over my career. Thank you @cshlbanbury.bsky.social and @themarkfdn.bsky.social

submitted 43 days ago • 1 comment

📢Funding opportunity! 📢 The Mark Foundation, @theaacr.bsky.social, and @lustgarten.org jointly seek proposals focused on accelerating the development of effective new approaches to the early detection of cancer. Learn more: themarkfoundation.org/early-detect... #CancerResearch #ResearchFunding

submitted 45 days ago • 0 comments

I love when wonderful people are recognized for their great science!!! Congrats to great friends, colleagues and inspirations @marasherman.bsky.social and Ansu Satpathy (get on Bluesky, brother!) and congrats to all awardees!!

submitted 45 days ago • 1 comment

📢Announcing The Mark Foundation 2025 Emerging Leader Award winners! 📢 These 5 outstanding early-career scientists will receive a total of $3.75M to pursue projects with the potential to transform cancer research. We can’t wait to see what they achieve! themarkfoundation.org/2025/01/the-...

submitted 47 days ago • 2 comments

“We’re not just funding research; we’re building a global network and pushing the boundaries of what’s possible.” Read @gevorgtamamyan.bsky.social's interview with Mark Foundation CEO Ryan Schoenfeld in @oncodaily.bsky.social & learn how we accelerate cancer research. oncodaily.com/dialogues/ry...

submitted 48 days ago • 0 comments

New Johnson & Johnson data shows that pairing the bispecific antibody amivantamab with lazertinib significantly extends survival of patients with EGFR-mutated #NSCLC. Last October, Mark Foundation CEO Ryan Schoenfeld told Biospace why he’s bullish on bispecifics: www.biospace.com/drug-develop...

submitted 54 days ago • 0 comments

Great insights from Mark Foundation Scientific Advisory Committee member @johannajoyce.bsky.social! #WomeninScience #WomeninSTEM

submitted 55 days ago • 0 comments

Congratulations to Mark Foundation Scientific Advisory Committee member Scott Armstrong! He’s been named one of @bosbizjournal.bsky.social’s 2025 Innovators in Healthcare for his work leading research and pediatric oncology at @danafarber.bsky.social. 👏👏 bizjournals.com/boston/news/...

submitted 56 days ago • 0 comments

What is the role of lactate accumulation in tumor growth and metastasis? @echouchani.bsky.social is using his Emerging Leader Award from The Mark Foundation to find out. Check out this new feature from @danafarber.bsky.social to learn more about his work! danafarberimpact.org/2024/12/canc...

submitted 57 days ago • 0 comments

Emerging Leader Award winner and ASPIRE grantee Dan Landau (@landau.bsky.social‬) has been busy! The Landau lab continues to revolutionize the field with a steady stream of new single-cell multi-omics techniques.

submitted 57 days ago • 0 comments

Hello, Bluesky! Follow along for updates on our work and the researchers we support. New to The Mark Foundation? Check out this video to learn how we accelerate progress in the fight against cancer. #CancerResearch #ResearchFunding vimeo.com/1013135446

submitted 59 days ago • 0 comments